Waste Management (WM) has been a notable topic in the bio-tech industry, with intense interest from institutional investors owning 82-83% of the company. Having completed a $7.2B purchase of
Stericycle, WM is fostering a strong standing in the
medical waste market. Rapid expansion of
recyclables and a drive to benefit both people and the planet is a realized objective, while initiatives like $100 million
MRF campuses are setting new growth trajectories. WM's stock has seen mixed behavior, with some days noting minor losses and others posting gains, even when markets underperform. However, trends suggest a strong momentum and growth stock, with recent
earnings and revenue surpassing Wall Street estimates. There are even claims that investors may undervalue the stock by 38%. The acquisition of
Winters Bros. Waste is expanding WM's New York footprint, and its merger with Stericycle has gained approvals in Canada. Conversely, some assert reasons to sell WM and decide on alternative investments. Final Christofferson Watershed details highlight WM's commitment to service amidst controversy over a new trash transfer station. The company's
Returns On Capital are increasing, as is its
dividend. WM 2024 Sustainability report accentuates their pledge to the environment and steady revenue growth.
Waste Management WM News Analytics from Wed, 15 May 2024 07:00:00 GMT to Thu, 09 Jan 2025 10:44:15 GMT -
Rating 7
- Innovation -3
- Information 9
- Rumor -4
